| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.726 | 0.021 | 0.726 | Caspase 9 stimulant | |||
| 0.592 | 0.004 | 0.592 | Alpha-N-acetylglucosaminidase inhibitor | 0.163 0.048 CID_179886 | ||
| 0.559 | 0.024 | 0.559 | Cholesterol antagonist | 0.484 0.035 CID_179886 | ||
| 0.546 | 0.014 | 0.546 | Calcium channel L-type activator | |||
| 0.529 | 0.029 | 0.529 | Aldehyde oxidase inhibitor | |||
| 0.499 | 0.027 | 0.499 | 5 Hydroxytryptamine release stimulant | |||
| 0.494 | 0.031 | 0.582 | Histamine release inhibitor | 0.582 0.012 CID_179886 | CID_179886 | |
| 0.479 | 0.032 | 0.479 | Vasodilator, peripheral | |||
| 0.446 | 0.005 | 0.446 | Neurotrophic factor enhancer | 0.147 0.142 CID_179886 | ||
| 0.481 | 0.043 | 0.481 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.286 0.233 CID_179886 | ||
| 0.472 | 0.034 | 0.472 | GABA C receptor rho-3 antagonist | 0.227 0.177 CID_179886 | ||
| 0.478 | 0.057 | 0.478 | Cyclophilin D inhibitor | 0.334 0.135 CID_179886 | ||
| 0.459 | 0.048 | 0.459 | 5 Hydroxytryptamine release inhibitor | |||
| 0.439 | 0.033 | 0.439 | Caspase 3 stimulant | |||
| 0.419 | 0.018 | 0.419 | Peroxidase inhibitor | 0.205 0.058 CID_179886 | ||
| 0.478 | 0.081 | 0.478 | Apoptosis agonist | 0.313 0.163 CID_179886 | ||
| 0.408 | 0.013 | 0.408 | 5 Hydroxytryptamine uptake stimulant | 0.199 0.154 CID_179886 | ||
| 0.394 | 0.004 | 0.394 | Porphobilinogen synthase inhibitor | 0.111 0.031 CID_179886 | ||
| 0.407 | 0.025 | 0.407 | Interleukin 2 agonist | |||
| 0.4 | 0.038 | 0.4 | Apoptosis antagonist | |||
| 0.362 | 0.005 | 0.362 | Carbonic anhydrase XV inhibitor | 0.189 0.02 CID_179886 | ||
| 0.367 | 0.027 | 0.367 | DNA synthesis inhibitor | 0.205 0.115 CID_179886 | ||
| 0.365 | 0.025 | 0.365 | Interleukin agonist | |||
| 0.338 | 0.004 | 0.469 | Triose-phosphate isomerase inhibitor | 0.469 0.003 CID_179886 | CID_179886 | |
| 0.341 | 0.008 | 0.341 | Aldehyde dehydrogenase inhibitor | |||
| 0.369 | 0.038 | 0.369 | Calcium channel activator | 0.234 0.167 CID_179886 | ||
| 0.364 | 0.037 | 0.364 | DNA damaging | |||
| 0.33 | 0.005 | 0.33 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.33 | 0.009 | 0.33 | UDP-glucose 4-epimerase inhibitor | 0.089 0.075 CID_179886 | ||
| 0.321 | 0.005 | 0.321 | Histidine decarboxylase inhibitor | |||
| 0.351 | 0.037 | 0.351 | Hypoglycemic | |||
| 0.316 | 0.003 | 0.316 | MAP3K9 inhibitor | 0.179 0.028 CID_179886 | ||
| 0.33 | 0.021 | 0.33 | Tyrosine 3 hydroxylase inhibitor | 0.191 0.152 CID_179886 | ||
| 0.309 | 0.003 | 0.309 | HIV-1 integrase (Overall Integration) inhibitor | 0.196 0.012 CID_179886 | ||
| 0.312 | 0.01 | 0.312 | Hexokinase inhibitor | |||
| 0.318 | 0.019 | 0.318 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.313 | 0.017 | 0.313 | Amylase inhibitor | |||
| 0.321 | 0.028 | 0.354 | RNA-directed DNA polymerase inhibitor | 0.354 0.023 CID_179886 | CID_179886 | |
| 0.36 | 0.074 | 0.36 | Transcription factor NF kappa B inhibitor | 0.215 0.155 CID_179886 | ||
| 0.292 | 0.01 | 0.292 | GABA C receptor agonist | |||
| 0.314 | 0.046 | 0.622 | Superoxide dismutase inhibitor | 0.622 0.006 CID_179886 | CID_179886 | |
| 0.285 | 0.019 | 0.285 | Protein kinase stimulant | |||
| 0.321 | 0.061 | 0.321 | Lipoxygenase inhibitor | 0.249 0.101 CID_179886 | ||
| 0.273 | 0.016 | 0.273 | Succinate dehydrogenase inhibitor | 0.195 0.053 CID_179886 | ||
| 0.276 | 0.019 | 0.276 | Nitric-oxide synthase stimulant | |||
| 0.325 | 0.069 | 0.325 | Vasodilator, coronary | |||
| 0.266 | 0.014 | 0.266 | DNA intercalator | |||
| 0.254 | 0.006 | 0.254 | CF transmembrane conductance regulator agonist | |||
| 0.252 | 0.004 | 0.252 | Glutamate release inhibitor | |||
| 0.252 | 0.006 | 0.252 | Photosensitizer | 0.126 0.051 CID_179886 | ||
| 0.257 | 0.012 | 0.257 | Bronchodilator | |||
| 0.317 | 0.078 | 0.517 | Antithrombotic | 0.517 0.027 CID_179886 | CID_179886 | |
| 0.247 | 0.009 | 0.247 | Carbonic anhydrase III inhibitor | 0.175 0.021 CID_179886 | ||
| 0.25 | 0.013 | 0.25 | Ferrochelatase inhibitor | |||
| 0.281 | 0.048 | 0.281 | Gastrin inhibitor | |||
| 0.282 | 0.049 | 0.282 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.273 | 0.041 | 0.273 | Anesthetic general | |||
| 0.245 | 0.013 | 0.245 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.242 | 0.01 | 0.242 | Toll-Like receptor 2 antagonist | |||
| 0.248 | 0.017 | 0.248 | Topoisomerase I inhibitor | |||
| 0.295 | 0.068 | 0.295 | Hypoxia-inducible factor 1 alpha inhibitor | 0.181 0.177 CID_179886 | ||
| 0.287 | 0.06 | 0.287 | Transcription factor STAT3 inhibitor | |||
| 0.242 | 0.016 | 0.242 | Cystathionine beta-synthase inhibitor | |||
| 0.249 | 0.025 | 0.399 | Phospholipase C inhibitor | 0.399 0.01 CID_179886 | CID_179886 | |
| 0.231 | 0.007 | 0.231 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.081 0.05 CID_179886 | ||
| 0.248 | 0.027 | 0.248 | NOS3 expression enhancer | |||
| 0.299 | 0.079 | 0.39 | Immunostimulant | 0.39 0.052 CID_179886 | CID_179886 | |
| 0.259 | 0.039 | 0.259 | Non-steroidal antiinflammatory agent | |||
| 0.226 | 0.009 | 0.226 | NADH dehydrogenase inhibitor | 0.12 0.028 CID_179886 | ||
| 0.29 | 0.074 | 0.29 | Spasmolytic | 0.263 0.086 CID_179886 | ||
| 0.282 | 0.066 | 0.282 | Transcription factor STAT inhibitor | |||
| 0.221 | 0.006 | 0.221 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.279 | 0.068 | 0.279 | Aryl hydrocarbon receptor agonist | |||
| 0.316 | 0.105 | 0.316 | Immunosuppressant | 0.206 0.191 CID_179886 | ||
| 0.221 | 0.011 | 0.221 | Carbonic anhydrase VI inhibitor | 0.134 0.025 CID_179886 | ||
| 0.28 | 0.072 | 0.28 | Insulysin inhibitor | |||
| 0.239 | 0.034 | 0.482 | Protein-tyrosine phosphatase inhibitor | 0.482 0.005 CID_179886 | CID_179886 | |
| 0.323 | 0.119 | 0.484 | Antibacterial | 0.484 0.045 CID_179886 | CID_179886 | |
| 0.273 | 0.073 | 0.273 | Antioxidant | 0.186 0.126 CID_179886 | ||
| 0.206 | 0.009 | 0.206 | Sphingomyelinase inhibitor | 0.094 0.067 CID_179886 | ||
| 0.21 | 0.013 | 0.22 | Carbonic anhydrase XIII inhibitor | 0.22 0.011 CID_179886 | CID_179886 | |
| 0.208 | 0.014 | 0.208 | Adenylate kinase inhibitor | 0.134 0.034 CID_179886 | ||
| 0.195 | 0.003 | 0.195 | Granulocyte macrophage colony stimulating factor agonist | 0.099 0.037 CID_179886 | ||
| 0.213 | 0.023 | 0.213 | Alkylator | 0.147 0.048 CID_179886 | ||
| 0.2 | 0.012 | 0.2 | Alcohol dehydrogenase inhibitor | 0.081 0.078 CID_179886 | ||
| 0.216 | 0.03 | 0.216 | Topoisomerase II inhibitor | |||
| 0.208 | 0.026 | 0.208 | DNA polymerase I inhibitor | |||
| 0.229 | 0.048 | 0.229 | Insulin sensitizer | |||
| 0.196 | 0.016 | 0.196 | Adenylate cyclase stimulant | 0.173 0.032 CID_179886 | ||
| 0.218 | 0.038 | 0.218 | 5 Hydroxytryptamine 3E antagonist | 0.175 0.12 CID_179886 | ||
| 0.205 | 0.026 | 0.205 | GABA C receptor rho-2 antagonist | |||
| 0.209 | 0.031 | 0.209 | ATPase inhibitor | |||
| 0.19 | 0.012 | 0.19 | Phosphofructokinase-1 inhibitor | 0.089 0.036 CID_179886 | ||
| 0.188 | 0.011 | 0.188 | Prolactin inhibitor | |||
| 0.185 | 0.01 | 0.185 | Keratolytic | |||
| 0.199 | 0.025 | 0.199 | 5-Lipoxygenase inhibitor | |||
| 0.19 | 0.017 | 0.286 | Catalase inhibitor | 0.286 0.006 CID_179886 | CID_179886 | |
| 0.202 | 0.031 | 0.202 | Arachidonic acid antagonist | 0.149 0.09 CID_179886 | ||
| 0.176 | 0.007 | 0.176 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.345 | 0.176 | 0.656 | Antiinflammatory | 0.656 0.039 CID_179886 | CID_179886 | |
| 0.268 | 0.099 | 0.268 | 12-Lipoxygenase inhibitor | |||
| 0.181 | 0.014 | 0.181 | Creatine kinase inhibitor | 0.115 0.045 CID_179886 | ||
| 0.175 | 0.009 | 0.175 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 CID_179886 | ||
| 0.172 | 0.007 | 0.172 | Leukotriene synthesis inhibitor | |||
| 0.184 | 0.02 | 0.184 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.18 | 0.018 | 0.18 | GABA C receptor antagonist | 0.152 0.029 CID_179886 | ||
| 0.181 | 0.019 | 0.181 | Mucolytic | |||
| 0.17 | 0.008 | 0.17 | Alcohol oxidase inhibitor | |||
| 0.174 | 0.016 | 0.174 | DNA repair enzyme inhibitor | 0.116 0.081 CID_179886 | ||
| 0.216 | 0.058 | 0.216 | I kappa B kinase epsilon inhibitor | |||
| 0.165 | 0.007 | 0.203 | Carbonic anhydrase VB inhibitor | 0.203 0.005 CID_179886 | CID_179886 | |
| 0.21 | 0.054 | 0.21 | Growth factor agonist | |||
| 0.176 | 0.02 | 0.176 | Protein kinase C gamma inhibitor | |||
| 0.168 | 0.014 | 0.168 | DOPA decarboxylase inhibitor | |||
| 0.188 | 0.035 | 0.26 | Cell wall synthesis inhibitor | 0.26 0.014 CID_179886 | CID_179886 | |
| 0.195 | 0.043 | 0.195 | Melanin inhibitor | |||
| 0.187 | 0.035 | 0.187 | Toll-Like receptor antagonist | |||
| 0.176 | 0.025 | 0.176 | Xanthine oxidase inhibitor | |||
| 0.179 | 0.029 | 0.179 | Nav1.6 sodium channel blocker | |||
| 0.16 | 0.01 | 0.16 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 CID_179886 | ||
| 0.2 | 0.052 | 0.2 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.166 | 0.021 | 0.166 | Heat shock protein 70 antagonist | |||
| 0.205 | 0.062 | 0.205 | Hepatoprotectant | 0.133 0.129 CID_179886 | ||
| 0.148 | 0.005 | 0.148 | Topoisomerase II beta inhibitor | |||
| 0.156 | 0.013 | 0.19 | Carbonic anhydrase V inhibitor | 0.19 0.008 CID_179886 | CID_179886 | |
| 0.177 | 0.036 | 0.252 | Protein-tyrosine phosphatase 1B inhibitor | 0.252 0.016 CID_179886 | CID_179886 | |
| 0.166 | 0.024 | 0.166 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.258 | 0.12 | 0.258 | Sodium/bile acid cotransporter inhibitor | 0.248 0.13 CID_179886 | ||
| 0.148 | 0.009 | 0.148 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.159 | 0.02 | 0.159 | Uric acid excretion stimulant | |||
| 0.221 | 0.084 | 0.84 | Angiogenesis stimulant | 0.84 0.003 CID_179886 | CID_179886 | |
| 0.155 | 0.019 | 0.155 | GABA C receptor rho-1 antagonist | |||
| 0.145 | 0.01 | 0.145 | Biliverdin reductase inhibitor | |||
| 0.182 | 0.047 | 0.182 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.137 | 0.004 | 0.137 | Glucosylceramidase inhibitor | |||
| 0.172 | 0.04 | 0.172 | Monophenol monooxygenase inhibitor | 0.132 0.055 CID_179886 | ||
| 0.149 | 0.018 | 0.149 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.142 | 0.014 | 0.142 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.266 | 0.138 | 0.266 | Calpain 2 inhibitor | |||
| 0.159 | 0.032 | 0.159 | Expectorant | |||
| 0.145 | 0.02 | 0.145 | Anabolic | 0.143 0.022 CID_179886 | ||
| 0.146 | 0.021 | 0.165 | Protein kinase C zeta inhibitor | 0.165 0.017 CID_179886 | CID_179886 | |
| 0.137 | 0.013 | 0.137 | Carbamoyl phosphate synthetase inhibitor | 0.082 0.028 CID_179886 | ||
| 0.177 | 0.052 | 0.177 | Interferon gamma antagonist | |||
| 0.162 | 0.038 | 0.258 | Antibacterial (Helicobacter pylori) | 0.258 0.011 CID_179886 | CID_179886 | |
| 0.17 | 0.046 | 0.17 | Nav1.2 sodium channel blocker | 0.137 0.066 CID_179886 | ||
| 0.142 | 0.018 | 0.142 | Transcription factor NF kappa B stimulant | |||
| 0.128 | 0.004 | 0.128 | Sphingosine kinase 2 inhibitor | |||
| 0.173 | 0.05 | 0.173 | MAO inhibitor | |||
| 0.201 | 0.079 | 0.201 | DNA methylase inhibitor | |||
| 0.149 | 0.029 | 0.149 | AMP-activated protein kinase stimulant | |||
| 0.16 | 0.04 | 0.16 | Cyclooxygenase 3 inhibitor | |||
| 0.131 | 0.013 | 0.131 | mTOR complex 2 inhibitor | |||
| 0.136 | 0.018 | 0.136 | Phosphodiesterase 3A inhibitor | |||
| 0.13 | 0.014 | 0.13 | Interferon agonist | 0.091 0.037 CID_179886 | ||
| 0.167 | 0.051 | 0.381 | Hemostatic | 0.381 0.009 CID_179886 | CID_179886 | |
| 0.131 | 0.015 | 0.136 | Carbonic anhydrase VA inhibitor | 0.136 0.014 CID_179886 | CID_179886 | |
| 0.122 | 0.007 | 0.122 | CD45 antagonist | 0.052 0.03 CID_179886 | ||
| 0.157 | 0.042 | 0.157 | Cathepsin H inhibitor | 0.104 0.1 CID_179886 | ||
| 0.198 | 0.084 | 0.198 | Anticonvulsant | |||
| 0.163 | 0.05 | 0.163 | MAP kinase 3 inhibitor | |||
| 0.131 | 0.019 | 0.131 | Ornithine decarboxylase inhibitor | |||
| 0.117 | 0.006 | 0.117 | Glutamate (mGluR6) antagonist | |||
| 0.131 | 0.02 | 0.131 | Glutamate dehydrogenase inhibitor | 0.076 0.049 CID_179886 | ||
| 0.154 | 0.043 | 0.154 | Adenylate cyclase inhibitor | |||
| 0.117 | 0.006 | 0.117 | Aconitate hydratase inhibitor | |||
| 0.149 | 0.038 | 0.208 | Aminopeptidase B inhibitor | 0.208 0.019 CID_179886 | CID_179886 | |
| 0.13 | 0.022 | 0.13 | Macrophage migration inhibitory factor inhibitor | |||
| 0.119 | 0.012 | 0.119 | Purinergic P2X1 antagonist | 0.075 0.028 CID_179886 | ||
| 0.182 | 0.075 | 0.182 | Nitric oxide antagonist | |||
| 0.111 | 0.005 | 0.111 | Liver X receptor alpha agonist | |||
| 0.119 | 0.013 | 0.119 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.183 | 0.078 | 0.183 | DNA methyltransferase I inhibitor | |||
| 0.129 | 0.025 | 0.133 | Cathepsin G inhibitor | 0.133 0.024 CID_179886 | CID_179886 | |
| 0.127 | 0.022 | 0.127 | Adrenaline agonist | |||
| 0.121 | 0.016 | 0.121 | Thioredoxin reductase inhibitor | |||
| 0.156 | 0.052 | 0.156 | MAP kinase kinase 4 inhibitor | |||
| 0.146 | 0.043 | 0.146 | Vanilloid 1 agonist | |||
| 0.199 | 0.098 | 0.199 | Free radical scavenger | |||
| 0.104 | 0.004 | 0.104 | Liver X receptor beta antagonist | |||
| 0.116 | 0.016 | 0.116 | D-Ala-D-Ala ligase inhibitor | |||
| 0.134 | 0.034 | 0.134 | Beta glucuronidase inhibitor | |||
| 0.175 | 0.077 | 0.679 | Dual specificity phosphatase 3 inhibitor | 0.679 0.004 CID_179886 | CID_179886 | |
| 0.14 | 0.041 | 0.14 | Falcipain 3 inhibitor | |||
| 0.103 | 0.005 | 0.103 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 CID_179886 | ||
| 0.105 | 0.007 | 0.105 | Sphingosine kinase inhibitor | 0.077 0.019 CID_179886 | ||
| 0.141 | 0.043 | 0.141 | Microtubule formation inhibitor | |||
| 0.124 | 0.027 | 0.124 | Toll-Like receptor 3 antagonist | |||
| 0.166 | 0.069 | 0.166 | Neurotensin receptor agonist | |||
| 0.103 | 0.006 | 0.162 | Alpha-mannosidase inhibitor | 0.162 0.004 CID_179886 | CID_179886 | |
| 0.11 | 0.013 | 0.11 | Prostaglandin E2 antagonist | |||
| 0.195 | 0.098 | 0.195 | Hypolipemic | |||
| 0.15 | 0.054 | 0.15 | NADPH oxidase inhibitor | |||
| 0.116 | 0.02 | 0.15 | Glycine receptor antagonist | 0.15 0.007 CID_179886 | CID_179886 | |
| 0.162 | 0.067 | 0.162 | Cytidine deaminase inhibitor | |||
| 0.108 | 0.013 | 0.108 | Xanthine dehydrogenase inhibitor | |||
| 0.099 | 0.005 | 0.099 | Liver X receptor beta agonist | |||
| 0.143 | 0.048 | 0.166 | Cholesterol synthesis inhibitor | 0.166 0.037 CID_179886 | CID_179886 | |
| 0.16 | 0.066 | 0.203 | Phospholipase A2 inhibitor | 0.203 0.041 CID_179886 | CID_179886 | |
| 0.204 | 0.11 | 0.204 | Calpain inhibitor | |||
| 0.131 | 0.038 | 0.131 | Estrogen antagonist | |||
| 0.115 | 0.022 | 0.115 | Glutamate decarboxylase inhibitor | |||
| 0.11 | 0.017 | 0.11 | Argininosuccinate synthase inhibitor | |||
| 0.102 | 0.01 | 0.102 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.029 CID_179886 | ||
| 0.121 | 0.03 | 0.121 | Thioredoxin inhibitor | |||
| 0.097 | 0.006 | 0.16 | Mannosidase inhibitor | 0.16 0.004 CID_179886 | CID_179886 | |
| 0.102 | 0.011 | 0.102 | MAP kinase kinase 7 inhibitor | |||
| 0.104 | 0.014 | 0.104 | Vanilloid 4 agonist | |||
| 0.116 | 0.026 | 0.116 | Bromodomain-containing protein 2 inhibitor | |||
| 0.168 | 0.079 | 0.168 | Tumour necrosis factor antagonist | |||
| 0.101 | 0.012 | 0.101 | Interferon inducer | 0.074 0.029 CID_179886 | ||
| 0.128 | 0.043 | 0.128 | Nav1.1 sodium channel blocker | |||
| 0.097 | 0.012 | 0.097 | Glutamate (mGluR7) antagonist | |||
| 0.109 | 0.024 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.117 0.018 CID_179886 | CID_179886 | |
| 0.111 | 0.025 | 0.111 | Myeloperoxidase inhibitor | |||
| 0.155 | 0.07 | 0.155 | Insulin secretagoues | |||
| 0.113 | 0.028 | 0.135 | Bile acid receptor antagonist | 0.135 0.011 CID_179886 | CID_179886 | |
| 0.119 | 0.034 | 0.119 | Estrogen receptor beta antagonist | |||
| 0.096 | 0.012 | 0.096 | Carbonic anhydrase XIV inhibitor | |||
| 0.131 | 0.047 | 0.131 | MAO A inhibitor | |||
| 0.111 | 0.027 | 0.111 | Somatostatin 1 agonist | |||
| 0.113 | 0.03 | 0.113 | CYP2A6 inhibitor | |||
| 0.145 | 0.062 | 0.145 | Pregnane X receptor agonist | 0.13 0.1 CID_179886 | ||
| 0.09 | 0.009 | 0.09 | Calcium channel P-type blocker | |||
| 0.091 | 0.01 | 0.091 | MDM2 inhibitor | |||
| 0.119 | 0.037 | 0.119 | Electrolyte absorption antagonist | |||
| 0.096 | 0.015 | 0.096 | Protein kinase C beta inhibitor | |||
| 0.18 | 0.1 | 0.18 | Histone acetyltransferase inhibitor | |||
| 0.085 | 0.005 | 0.085 | Liver X receptor antagonist | |||
| 0.096 | 0.017 | 0.134 | Phospholipase D inhibitor | 0.134 0.004 CID_179886 | CID_179886 | |
| 0.1 | 0.021 | 0.1 | Glycine receptor agonist | |||
| 0.086 | 0.007 | 0.086 | Lysophosphatidic acid 3 receptor antagonist | 0.057 0.026 CID_179886 | ||
| 0.126 | 0.048 | 0.126 | MAO B inhibitor | |||
| 0.103 | 0.026 | 0.103 | Aminopeptidase I inhibitor | |||
| 0.099 | 0.022 | 0.099 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.16 | 0.084 | 0.16 | Catenin beta inhibitor | |||
| 0.08 | 0.004 | 0.08 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.089 | 0.014 | 0.089 | Phosphodiesterase 1C inhibitor | |||
| 0.121 | 0.047 | 0.121 | Mediator release inhibitor | |||
| 0.121 | 0.047 | 0.131 | Acetylcholine release stimulant | 0.131 0.033 CID_179886 | CID_179886 | |
| 0.077 | 0.003 | 0.081 | Guanylate cyclase inhibitor | 0.081 0.003 CID_179886 | CID_179886 | |
| 0.094 | 0.021 | 0.094 | GABA B receptor agonist | |||
| 0.08 | 0.007 | 0.08 | Retinoid X alpha receptor agonist | |||
| 0.186 | 0.113 | 0.186 | Platelet antagonist | 0.178 0.119 CID_179886 | ||
| 0.088 | 0.015 | 0.088 | Phosphorylase inhibitor | 0.052 0.029 CID_179886 | ||
| 0.105 | 0.033 | 0.105 | ATPase (Vacuolar H+) inhibitor | |||
| 0.077 | 0.005 | 0.077 | Cytokine production stimulant | |||
| 0.125 | 0.053 | 0.125 | TRPA1 agonist | 0.107 0.077 CID_179886 | ||
| 0.171 | 0.099 | 0.171 | Psychostimulant | |||
| 0.079 | 0.008 | 0.079 | Thymidylate synthase inhibitor | |||
| 0.084 | 0.013 | 0.084 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.11 | 0.039 | 0.11 | ABCA1 expression enhancer | |||
| 0.075 | 0.004 | 0.075 | Liver X receptor alpha antagonist | |||
| 0.098 | 0.028 | 0.098 | Estrogen receptor alpha antagonist | |||
| 0.098 | 0.028 | 0.098 | Estrogen-related receptor beta agonist | |||
| 0.105 | 0.036 | 0.105 | Topoisomerase II alpha inhibitor | |||
| 0.09 | 0.022 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.071 0.056 CID_179886 | ||
| 0.089 | 0.021 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | 0.087 0.022 CID_179886 | ||
| 0.144 | 0.075 | 0.144 | Thiol protease inhibitor | |||
| 0.098 | 0.03 | 0.098 | Caspase 7 inhibitor | |||
| 0.078 | 0.01 | 0.078 | Beta 2 adrenoreceptor agonist | |||
| 0.097 | 0.029 | 0.097 | GABA aminotransferase inhibitor | |||
| 0.071 | 0.003 | 0.071 | Ceramide glucosyltransferase inhibitor | 0.064 0.004 CID_179886 | ||
| 0.073 | 0.005 | 0.073 | Sphingosine kinase 1 inhibitor | |||
| 0.071 | 0.004 | 0.071 | Sodium/glucose cotransporter inhibitor | |||
| 0.107 | 0.04 | 0.107 | Histamine N-methyltransferase inhibitor | |||
| 0.123 | 0.056 | 0.123 | Caspase 3 inhibitor | |||
| 0.155 | 0.089 | 0.672 | Dual specificity phosphatase inhibitor | 0.672 0.004 CID_179886 | CID_179886 | |
| 0.133 | 0.068 | 0.133 | Cyclooxygenase 2 inhibitor | |||
| 0.082 | 0.017 | 0.082 | Dihydroorotate dehydrogenase inhibitor | 0.045 0.043 CID_179886 | ||
| 0.169 | 0.105 | 0.169 | MAP kinase kinase 2 inhibitor | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | |||
| 0.07 | 0.007 | 0.07 | GABA uptake inhibitor | |||
| 0.141 | 0.078 | 0.141 | Cyclooxygenase inhibitor | |||
| 0.068 | 0.005 | 0.068 | Free fatty acid receptor 1 antagonist | |||
| 0.074 | 0.011 | 0.074 | Adenosine deaminase inhibitor | 0.07 0.013 CID_179886 | ||
| 0.178 | 0.116 | 0.178 | Antiamyloidogenic | |||
| 0.114 | 0.051 | 0.114 | Urease inhibitor | |||
| 0.105 | 0.043 | 0.123 | Phosphodiesterase 6D inhibitor | 0.123 0.022 CID_179886 | CID_179886 | |
| 0.107 | 0.046 | 0.107 | Protein kinase C delta inhibitor | |||
| 0.071 | 0.011 | 0.141 | Heparanase inhibitor | 0.141 0.003 CID_179886 | CID_179886 | |
| 0.107 | 0.047 | 0.107 | Glutamate (mGluR7) agonist | |||
| 0.127 | 0.067 | 0.127 | Nav1.3 sodium channel blocker | |||
| 0.118 | 0.058 | 0.118 | Nav1.5 sodium channel blocker | |||
| 0.082 | 0.022 | 0.102 | Estrogen agonist | 0.102 0.017 CID_179886 | CID_179886 | |
| 0.18 | 0.121 | 0.18 | Vasodilator | |||
| 0.066 | 0.007 | 0.066 | Glutamate (mGluR3) antagonist | |||
| 0.063 | 0.005 | 0.063 | Uridine phosphorylase inhibitor | |||
| 0.068 | 0.011 | 0.068 | Retinoid X receptor agonist | |||
| 0.132 | 0.075 | 0.132 | Bone formation stimulant | |||
| 0.081 | 0.024 | 0.081 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.085 | 0.029 | 0.085 | Leukotriene antagonist | |||
| 0.081 | 0.024 | 0.081 | Exportin-1 inhibitor | |||
| 0.122 | 0.066 | 0.122 | Anesthetic local | |||
| 0.12 | 0.065 | 0.12 | Proteasome inhibitor | |||
| 0.128 | 0.073 | 0.128 | Cyclooxygenase 1 inhibitor | |||
| 0.068 | 0.013 | 0.068 | Liver X receptor agonist | |||
| 0.135 | 0.08 | 0.135 | Activin receptor-like kinase 2 inhibitor | |||
| 0.075 | 0.021 | 0.075 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.087 | 0.033 | 0.397 | Selectin antagonist | 0.397 0.003 CID_179886 | CID_179886 | |
| 0.08 | 0.027 | 0.08 | Prostaglandin EP2 antagonist | |||
| 0.062 | 0.008 | 0.062 | Nerve growth factor antagonist | |||
| 0.105 | 0.052 | 0.105 | Potassium channel (Ca-activated) activator | |||
| 0.131 | 0.079 | 0.131 | Neurotrophic factor | |||
| 0.059 | 0.007 | 0.059 | Angiotensin AT1 receptor antagonist | |||
| 0.067 | 0.015 | 0.067 | Squalene epoxidase inhibitor | |||
| 0.064 | 0.014 | 0.064 | Sphingosine 1-phosphate receptor agonist | |||
| 0.055 | 0.005 | 0.055 | Estrogen-related receptor beta antagonist | |||
| 0.07 | 0.02 | 0.07 | Leukotriene B4 antagonist | 0.053 0.039 CID_179886 | ||
| 0.062 | 0.012 | 0.062 | Geranyltranstransferase inhibitor | |||
| 0.059 | 0.01 | 0.059 | Fumarate hydratase inhibitor | |||
| 0.066 | 0.018 | 0.066 | Phosphodiesterase 3B inhibitor | |||
| 0.061 | 0.013 | 0.061 | Thymidine kinase inhibitor | 0.039 0.032 CID_179886 | ||
| 0.096 | 0.049 | 0.096 | Phosphodiesterase I inhibitor | |||
| 0.067 | 0.02 | 0.067 | DNA helicase inhibitor | |||
| 0.147 | 0.1 | 0.147 | LIM domain kinase 1 inhibitor | |||
| 0.08 | 0.033 | 0.08 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.053 | 0.006 | 0.053 | CF transmembrane conductance regulator antagonist | |||
| 0.057 | 0.011 | 0.057 | Diamine oxidase inhibitor | |||
| 0.07 | 0.023 | 0.07 | Prolactin release inhibitor | |||
| 0.188 | 0.143 | 0.188 | Neuropeptide Y2 antagonist | |||
| 0.066 | 0.021 | 0.066 | Thromboxane synthase inhibitor | |||
| 0.058 | 0.014 | 0.058 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.074 | 0.029 | 0.074 | Beta 3 adrenoreceptor antagonist | |||
| 0.07 | 0.026 | 0.07 | Ornithine carbamoyltransferase inhibitor | |||
| 0.053 | 0.01 | 0.053 | Glutamate (mGluR8) agonist | |||
| 0.05 | 0.007 | 0.05 | Angiotensin II receptor antagonist | |||
| 0.064 | 0.021 | 0.064 | Leukotriene C antagonist | |||
| 0.089 | 0.046 | 0.089 | Glutamate receptor agonist | |||
| 0.072 | 0.029 | 0.072 | Phosphodiesterase 1B inhibitor | |||
| 0.072 | 0.029 | 0.072 | Androgen agonist | |||
| 0.075 | 0.032 | 0.075 | CDC25B inhibitor | |||
| 0.074 | 0.032 | 0.074 | Beta adrenoreceptor antagonist | |||
| 0.056 | 0.014 | 0.056 | Dopamine D5 agonist | |||
| 0.108 | 0.067 | 0.108 | Chelator | |||
| 0.06 | 0.018 | 0.06 | Factor III inhibitor | |||
| 0.089 | 0.048 | 0.089 | Glutathione S-transferase inhibitor | |||
| 0.063 | 0.022 | 0.063 | Potassium channel (Inward rectifier) blocker | |||
| 0.047 | 0.006 | 0.047 | Prostaglandin EP2 agonist | |||
| 0.055 | 0.015 | 0.055 | GABA B receptor antagonist | |||
| 0.048 | 0.008 | 0.048 | Melatonin receptor 1A agonist | |||
| 0.112 | 0.073 | 0.112 | Interleukin 8 antagonist | |||
| 0.068 | 0.029 | 0.068 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.113 | 0.074 | 0.113 | Transcription factor STAT6 inhibitor | |||
| 0.051 | 0.013 | 0.051 | Kainate receptor agonist | |||
| 0.051 | 0.013 | 0.051 | Heme oxygenase inhibitor | |||
| 0.066 | 0.028 | 0.066 | Prostaglandin antagonist | |||
| 0.07 | 0.033 | 0.07 | NMDA 2C receptor antagonist | 0.065 0.038 CID_179886 | ||
| 0.053 | 0.015 | 0.064 | Dihydrofolate reductase inhibitor | 0.064 0.008 CID_179886 | CID_179886 | |
| 0.052 | 0.015 | 0.052 | Glutamate (mGluR group II) antagonist | |||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.052 | 0.015 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.068 | 0.031 | 0.068 | Histone deacetylase SIRT3 inhibitor | |||
| 0.134 | 0.097 | 0.134 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.05 | 0.014 | 0.066 | Farnesoid X receptor agonist | 0.066 0.008 CID_179886 | CID_179886 | |
| 0.05 | 0.014 | 0.065 | Phosphoglycerate kinase inhibitor | 0.065 0.01 CID_179886 | CID_179886 | |
| 0.136 | 0.101 | 0.136 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.126 | 0.091 | 0.126 | Farnesoid X receptor antagonist | |||
| 0.061 | 0.026 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.076 | 0.042 | 0.076 | Prostaglandin-E synthase inhibitor | |||
| 0.048 | 0.014 | 0.048 | Prostacyclin antagonist | |||
| 0.061 | 0.027 | 0.061 | Thromboxane A2 antagonist | |||
| 0.072 | 0.038 | 0.072 | Potassium channel (ATP-sensitive) blocker | |||
| 0.064 | 0.03 | 0.064 | Thromboxane antagonist | |||
| 0.131 | 0.097 | 0.131 | Heat shock protein 90 antagonist | |||
| 0.043 | 0.01 | 0.043 | Purinergic P2Y14 antagonist | |||
| 0.137 | 0.104 | 0.137 | Mcl-1 antagonist | |||
| 0.105 | 0.072 | 0.105 | GABA receptor agonist | |||
| 0.134 | 0.102 | 0.134 | Growth hormone agonist | |||
| 0.047 | 0.015 | 0.047 | Retinoid X receptor antagonist | |||
| 0.064 | 0.032 | 0.064 | Beta 1 adrenoreceptor antagonist | |||
| 0.049 | 0.017 | 0.049 | Estrogen receptor alpha agonist | |||
| 0.053 | 0.021 | 0.053 | Dihydroorotase inhibitor | |||
| 0.042 | 0.01 | 0.042 | Prostaglandin EP4 antagonist | |||
| 0.072 | 0.041 | 0.072 | Protein kinase C alpha inhibitor | |||
| 0.058 | 0.026 | 0.058 | Beta 2 adrenoreceptor antagonist | |||
| 0.23 | 0.199 | 0.23 | Alpha-glucosidase inhibitor | |||
| 0.065 | 0.034 | 0.065 | Cyclin D1 inhibitor | |||
| 0.06 | 0.029 | 0.06 | Lysine-specific demethylase 1A inhibitor | |||
| 0.061 | 0.03 | 0.061 | Toll-Like receptor 8 antagonist | |||
| 0.058 | 0.028 | 0.058 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.06 | 0.029 | 0.06 | Dihydroorotate oxidase inhibitor | |||
| 0.036 | 0.006 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 CID_179886 | ||
| 0.053 | 0.023 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.034 | 0.005 | 0.034 | Free fatty acid receptor 1 agonist | |||
| 0.053 | 0.024 | 0.053 | CC chemokine 4 receptor antagonist | |||
| 0.22 | 0.191 | 0.355 | 15-Lipoxygenase inhibitor | 0.355 0.097 CID_179886 | CID_179886 | |
| 0.057 | 0.027 | 0.057 | Antimetabolite | |||
| 0.034 | 0.005 | 0.034 | ICAM 1 antagonist | |||
| 0.107 | 0.078 | 0.251 | Cell adhesion inhibitor | 0.251 0.015 CID_179886 | CID_179886 | |
| 0.042 | 0.013 | 0.042 | Prostaglandin agonist | |||
| 0.12 | 0.091 | 0.12 | Histone deacetylase SIRT1 inhibitor | |||
| 0.053 | 0.025 | 0.053 | Dopamine beta hydroxylase inhibitor | |||
| 0.061 | 0.033 | 0.061 | Protein kinase C eta inhibitor | |||
| 0.059 | 0.031 | 0.09 | Adenine nucleotide translocase inhibitor | 0.09 0.006 CID_179886 | CID_179886 | |
| 0.035 | 0.007 | 0.035 | Hedgehog signaling activator | |||
| 0.051 | 0.023 | 0.051 | Purinergic P2X4 antagonist | |||
| 0.045 | 0.018 | 0.045 | Retinoic acid alpha receptor agonist | |||
| 0.035 | 0.008 | 0.035 | Nicotinic acid receptor 2 antagonist | |||
| 0.039 | 0.013 | 0.039 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.051 | 0.024 | 0.051 | NMDA receptor subunit 3B antagonist | |||
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | |||
| 0.053 | 0.026 | 0.053 | Cholesterol esterase inhibitor | |||
| 0.035 | 0.008 | 0.035 | Thymidine phosphorylase inhibitor | |||
| 0.062 | 0.036 | 0.066 | Carbonic anhydrase IX inhibitor | 0.066 0.034 CID_179886 | CID_179886 | |
| 0.055 | 0.029 | 0.055 | Prolyl endopeptidase inhibitor | |||
| 0.039 | 0.013 | 0.039 | ATP citrate lysase inhibitor | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.19 | 0.164 | 0.19 | Prostaglandin dehydrogenase inhibitor | |||
| 0.1 | 0.075 | 0.1 | 5 Hydroxytryptamine 3A agonist | |||
| 0.042 | 0.017 | 0.042 | RNA-directed RNA polymerase inhibitor | |||
| 0.192 | 0.167 | 0.192 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.04 | 0.015 | 0.04 | Retinoid X alpha receptor antagonist | |||
| 0.063 | 0.039 | 0.063 | Aromatase inhibitor | |||
| 0.053 | 0.028 | 0.074 | Glutamate (mGluR group I) agonist | 0.074 0.014 CID_179886 | CID_179886 | |
| 0.048 | 0.024 | 0.048 | Glutamate (mGluR group III) antagonist | |||
| 0.065 | 0.041 | 0.118 | NMDA receptor agonist | 0.118 0.014 CID_179886 | CID_179886 | |
| 0.031 | 0.007 | 0.031 | Complement factor 1s inhibitor | |||
| 0.077 | 0.053 | 0.077 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.044 | 0.02 | 0.044 | TRPM8 blocker | |||
| 0.084 | 0.061 | 0.154 | NMDA receptor antagonist | 0.154 0.023 CID_179886 | CID_179886 | |
| 0.092 | 0.069 | 0.092 | Interleukin 12 antagonist | |||
| 0.091 | 0.068 | 0.091 | MAP kinase kinase 1 inhibitor | |||
| 0.028 | 0.005 | 0.028 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.106 | 0.084 | 0.106 | Histone deacetylase class III inhibitor | |||
| 0.042 | 0.02 | 0.042 | Leukotriene C4 antagonist | |||
| 0.036 | 0.014 | 0.036 | Glutamate (mGluR2) antagonist | |||
| 0.194 | 0.172 | 0.194 | Immunomodulator | |||
| 0.082 | 0.06 | 0.082 | GABA A receptor agonist | |||
| 0.044 | 0.022 | 0.044 | Urate transporter 1 inhibitor | |||
| 0.178 | 0.157 | 0.178 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.031 | 0.01 | 0.031 | Prostaglandin E2 agonist | |||
| 0.03 | 0.009 | 0.03 | Vanilloid 2 agonist | 0.024 0.02 CID_179886 | ||
| 0.034 | 0.013 | 0.168 | NMDA 2D receptor antagonist | 0.168 0.003 CID_179886 | CID_179886 | |
| 0.058 | 0.038 | 0.058 | Fatty acid synthase inhibitor | |||
| 0.105 | 0.084 | 0.105 | Acetylcholine muscarinic antagonist | |||
| 0.044 | 0.024 | 0.044 | Plasmepsin II inhibitor | |||
| 0.063 | 0.043 | 0.063 | NMDA receptor glycine site agonist | |||
| 0.026 | 0.006 | 0.026 | G-protein-coupled receptor 120 agonist | |||
| 0.039 | 0.018 | 0.039 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.029 | 0.009 | 0.029 | Retinoid X beta receptor agonist | |||
| 0.115 | 0.095 | 0.121 | Cytokine production inhibitor | 0.121 0.089 CID_179886 | CID_179886 | |
| 0.064 | 0.044 | 0.064 | Transcription factor RelA inhibitor | |||
| 0.04 | 0.021 | 0.04 | Integrin alpha2 antagonist | |||
| 0.059 | 0.04 | 0.059 | Ryanodine receptor antagonist | |||
| 0.029 | 0.01 | 0.029 | Adenosine kinase inhibitor | |||
| 0.025 | 0.006 | 0.025 | Toll-Like receptor 8 agonist | |||
| 0.064 | 0.046 | 0.064 | Aryl hydrocarbon receptor antagonist | |||
| 0.036 | 0.017 | 0.036 | HCV NS5B polymerase inhibitor | |||
| 0.057 | 0.039 | 0.057 | Pregnane X receptor antagonist | |||
| 0.038 | 0.02 | 0.038 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.112 | 0.094 | 0.112 | Sodium channel (voltage-gated) blocker | |||
| 0.029 | 0.011 | 0.067 | Glutamate (mGluR1) agonist | 0.067 0.004 CID_179886 | CID_179886 | |
| 0.062 | 0.044 | 0.062 | I kappa B kinase 2 inhibitor | |||
| 0.035 | 0.017 | 0.035 | Glutamate (mGluR3) agonist | |||
| 0.029 | 0.012 | 0.029 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.068 | 0.051 | 0.068 | HIV-1 integrase inhibitor | |||
| 0.072 | 0.054 | 0.374 | CDC25A inhibitor | 0.374 0.003 CID_179886 | CID_179886 | |
| 0.041 | 0.024 | 0.041 | Alpha 1d adrenoreceptor agonist | |||
| 0.047 | 0.03 | 0.078 | Glutamate (mGluR5) agonist | 0.078 0.011 CID_179886 | CID_179886 | |
| 0.026 | 0.009 | 0.026 | Imidazoline I1 receptor antagonist | |||
| 0.034 | 0.017 | 0.034 | Glucagon receptor antagonist | |||
| 0.045 | 0.028 | 0.045 | AICAR transformylase inhibitor | |||
| 0.04 | 0.023 | 0.04 | Arginase inhibitor | |||
| 0.083 | 0.066 | 0.083 | Interleukin 5 antagonist | |||
| 0.03 | 0.013 | 0.03 | Integrin alpha2beta1 antagonist | |||
| 0.041 | 0.024 | 0.041 | Aggrecanase 1 inhibitor | |||
| 0.023 | 0.007 | 0.023 | Antibiotic Anthracycline-like | |||
| 0.021 | 0.006 | 0.021 | Telomerase stimulant | |||
| 0.026 | 0.011 | 0.026 | Geranylgeranyltransferase inhibitor | |||
| 0.121 | 0.106 | 0.121 | Acetylcholine M1 receptor antagonist | |||
| 0.04 | 0.025 | 0.04 | MAP3K5 inhibitor | |||
| 0.023 | 0.009 | 0.023 | Retinoid X beta receptor antagonist | |||
| 0.039 | 0.024 | 0.039 | Vanilloid 3 antagonist | |||
| 0.028 | 0.013 | 0.028 | Acid ceramidase inhibitor | |||
| 0.06 | 0.046 | 0.138 | Carbonic anhydrase inhibitor | 0.138 0.018 CID_179886 | CID_179886 | |
| 0.102 | 0.088 | 0.102 | Beta amyloid protein antagonist | |||
| 0.064 | 0.05 | 0.064 | Bcl2 antagonist | |||
| 0.046 | 0.032 | 0.046 | Adenylate cyclase 1 inhibitor | |||
| 0.071 | 0.057 | 0.071 | Adenosine A3 receptor antagonist | |||
| 0.033 | 0.02 | 0.033 | Cholesterol ester transfer protein antagonist | |||
| 0.037 | 0.024 | 0.037 | Nicotinic acid receptor agonist | |||
| 0.113 | 0.101 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.026 | 0.013 | 0.026 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.079 | 0.066 | 0.079 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.058 | 0.046 | 0.058 | Alpha 2 adrenoreceptor agonist | |||
| 0.017 | 0.005 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.032 | 0.02 | 0.032 | Prostaglandin EP3 antagonist | |||
| 0.051 | 0.039 | 0.051 | Autotaxin inhibitor | |||
| 0.024 | 0.012 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.024 | 0.013 | 0.024 | Beta 1 adrenoreceptor agonist | |||
| 0.023 | 0.012 | 0.023 | Prostaglandin EP1 antagonist | |||
| 0.049 | 0.037 | 0.049 | Sodium/calcium exchanger inhibitor | |||
| 0.033 | 0.022 | 0.033 | Melatonin 2 agonist | |||
| 0.024 | 0.013 | 0.131 | Glutamate (mGluR1a) agonist | 0.131 0.003 CID_179886 | CID_179886 | |
| 0.038 | 0.027 | 0.038 | NMDA receptor subunit 3A antagonist | |||
| 0.024 | 0.014 | 0.024 | Leukotriene B4 receptor 2 antagonist | |||
| 0.06 | 0.05 | 0.06 | Neutrophil collagenase inhibitor | |||
| 0.037 | 0.027 | 0.037 | 5-Alpha-reductase inhibitor | |||
| 0.089 | 0.08 | 0.111 | Gastric antisecretory | 0.111 0.052 CID_179886 | CID_179886 | |
| 0.055 | 0.045 | 0.179 | HIV-1 integrase (Strand Transfer) inhibitor | 0.179 0.011 CID_179886 | CID_179886 | |
| 0.018 | 0.009 | 0.018 | Adenosine A2a receptor agonist | |||
| 0.067 | 0.057 | 0.067 | Calcium channel L-type blocker | |||
| 0.056 | 0.047 | 0.056 | Heat shock protein 90 beta antagonist | |||
| 0.016 | 0.007 | 0.016 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.041 | 0.032 | 0.041 | DNA gyrase subunit A inhibitor | |||
| 0.024 | 0.015 | 0.024 | Retinoid X gamma receptor agonist | |||
| 0.045 | 0.037 | 0.045 | Aldosterone antagonist | |||
| 0.018 | 0.009 | 0.018 | Adenosine A2 receptor agonist | |||
| 0.02 | 0.011 | 0.02 | Alpha 2b adrenoreceptor agonist | |||
| 0.027 | 0.018 | 0.027 | Calcium-sensing receptor agonist | |||
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | |||
| 0.119 | 0.111 | 0.374 | Thrombolytic | 0.374 0.014 CID_179886 | CID_179886 | |
| 0.028 | 0.02 | 0.028 | Purinergic P2Y15 antagonist | |||
| 0.019 | 0.011 | 0.019 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.077 | 0.069 | 0.077 | Androgen antagonist | |||
| 0.048 | 0.04 | 0.048 | Carbonic anhydrase XII inhibitor | |||
| 0.052 | 0.044 | 0.052 | Bruton tyrosine kinase inhibitor | |||
| 0.082 | 0.074 | 0.082 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.075 | 0.068 | 0.075 | Calcium antagonist | |||
| 0.026 | 0.018 | 0.026 | Thyroid hormone agonist | |||
| 0.064 | 0.057 | 0.128 | NMDA 2 receptor antagonist | 0.128 0.022 CID_179886 | CID_179886 | |
| 0.078 | 0.071 | 0.078 | CC chemokine 5 receptor agonist | |||
| 0.016 | 0.009 | 0.018 | Purinergic P2Y1 agonist | 0.018 0.008 CID_179886 | CID_179886 | |
| 0.037 | 0.031 | 0.037 | Membrane dipeptidase inhibitor | |||
| 0.026 | 0.02 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Prostaglandin EP4 agonist | |||
| 0.014 | 0.008 | 0.014 | Integrin beta2 antagonist | |||
| 0.116 | 0.11 | 0.208 | Diuretic | 0.208 0.041 CID_179886 | CID_179886 | |
| 0.043 | 0.037 | 0.043 | Carbonic anhydrase VII inhibitor | |||
| 0.018 | 0.012 | 0.018 | Complement factor D inhibitor | |||
| 0.02 | 0.014 | 0.02 | Caspase 8 inhibitor | |||
| 0.086 | 0.08 | 0.086 | MAP kinase kinase kinase inhibitor | |||
| 0.041 | 0.036 | 0.041 | Oleamide hydrolase inhibitor | |||
| 0.065 | 0.06 | 0.065 | Secretase beta inhibitor | |||
| 0.085 | 0.081 | 0.085 | Alpha 2c adrenoreceptor antagonist | |||
| 0.054 | 0.049 | 0.054 | Acetylcholine M3 receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.017 | 0.012 | 0.017 | Ileal bile acid transport inhibitor | |||
| 0.056 | 0.051 | 0.056 | 5 Hydroxytryptamine 2A agonist | |||
| 0.047 | 0.043 | 0.047 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.029 | 0.024 | 0.029 | Prostaglandin D2 agonist | |||
| 0.019 | 0.015 | 0.019 | Retinoic acid beta receptor agonist | |||
| 0.148 | 0.144 | 0.148 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.043 | 0.039 | 0.043 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.028 | 0.024 | 0.028 | Estrogen receptor beta agonist | |||
| 0.066 | 0.062 | 0.066 | Acetylcholine M4 receptor antagonist | |||
| 0.017 | 0.013 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.01 | 0.007 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CID_179886 | ||
| 0.035 | 0.031 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.024 | 0.021 | 0.024 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.029 | 0.026 | 0.029 | Sirtuin 2 inhibitor | |||
| 0.021 | 0.018 | 0.021 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.02 | 0.017 | 0.02 | Neuraminidase (Influenza B) inhibitor | |||
| 0.091 | 0.088 | 0.091 | Toll-Like receptor 4 antagonist | |||
| 0.047 | 0.044 | 0.047 | Ribonucleotide reductase inhibitor | |||
| 0.064 | 0.061 | 0.064 | Benzodiazepine agonist | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.128 | 0.126 | 0.128 | Antipruritic | |||
| 0.048 | 0.045 | 0.08 | Carbonic anhydrase I inhibitor | 0.08 0.025 CID_179886 | CID_179886 | |
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.025 | 0.022 | 0.025 | Leukotriene B4 receptor 1 antagonist | |||
| 0.023 | 0.02 | 0.023 | Prostaglandin H2 antagonist | |||
| 0.02 | 0.018 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.077 | 0.075 | 0.077 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | |||
| 0.023 | 0.021 | 0.023 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.048 | 0.046 | 0.062 | Carbonic anhydrase II inhibitor | 0.062 0.034 CID_179886 | CID_179886 | |
| 0.025 | 0.024 | 0.025 | LFA antagonist | |||
| 0.107 | 0.105 | 0.164 | Alkaline phosphatase inhibitor | 0.164 0.051 CID_179886 | CID_179886 | |
| 0.01 | 0.009 | 0.01 | Thromboxane agonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.09 | 0.093 | 0.124 | Nav1.4 sodium channel blocker | 0.124 0.049 CID_179886 | CID_179886 | |
| 0.068 | 0.074 | 0.366 | Cell adhesion molecule inhibitor | 0.366 0.005 CID_179886 | CID_179886 | |
| 0.068 | 0.076 | 0.084 | Chymotrypsin inhibitor | 0.084 0.049 CID_179886 | CID_179886 | |
| 0.049 | 0.065 | 0.137 | HIV-1 integrase (3'-Processing) inhibitor | 0.137 0.015 CID_179886 | CID_179886 | |
| 0.032 | 0.05 | 0.087 | Leukocyte elastase inhibitor | 0.087 0.011 CID_179886 | CID_179886 | |
| 0.016 | 0.034 | 0.019 | Follicle-stimulating hormone antagonist | 0.019 0.016 CID_179886 | CID_179886 | |
| 0.024 | 0.051 | 0.072 | Purinergic P2Y2 antagonist | 0.072 0.006 CID_179886 | CID_179886 | |
| 0.019 | 0.069 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_179886 | CID_179886 | |
| 0.033 | 0.098 | 0.287 | Factor IXa inhibitor | 0.287 0.002 CID_179886 | CID_179886 | |
| 0.015 | 0.087 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_179886 | CID_179886 | |
| 0.099 | 0.177 | 0.291 | Platelet adhesion inhibitor | 0.291 0.037 CID_179886 | CID_179886 | |
| 0.005 | 0.132 | 0.088 | Estrone sulfatase inhibitor | 0.088 0.005 CID_179886 | CID_179886 | |
| 0.011 | 0.143 | 0.086 | Factor Xa inhibitor | 0.086 0.017 CID_179886 | CID_179886 | |
| 0.015 | 0.21 | 0.596 | Cholecystokinin B agonist | 0.596 0.002 CID_179886 | CID_179886 | |
| 0.021 | 0.225 | 0.13 | Neuraminidase (influenza) inhibitor | 0.13 0.01 CID_179886 | CID_179886 | |
| 0.018 | 0.243 | 0.304 | NMDA 2B receptor antagonist | 0.304 0.004 CID_179886 | CID_179886 | |
| 0.012 | 0.254 | 0.075 | Neuraminidase inhibitor | 0.075 0.029 CID_179886 | CID_179886 | |
| 0.004 | 0.266 | 0.22 | Cholecystokinin A antagonist | 0.22 0.004 CID_179886 | CID_179886 | |
| 0.045 | 0.324 | 0.849 | Anticoagulant | 0.849 0.004 CID_179886 | CID_179886 | |
| 0.004 | 0.286 | 0.387 | Cholecystokinin A agonist | 0.387 0.002 CID_179886 | CID_179886 | |
| 0.004 | 0.288 | 0.118 | Cholecystokinin B antagonist | 0.118 0.005 CID_179886 | CID_179886 | |
| 0.005 | 0.298 | 0.139 | Cholecystokinin antagonist | 0.139 0.005 CID_179886 | CID_179886 | |
| 0.013 | 0.308 | 0.119 | Elastase inhibitor | 0.119 0.006 CID_179886 | CID_179886 | |
| 0.02 | 0.323 | 0.115 | Fibroblast growth factor 1 antagonist | 0.115 0.046 CID_179886 | CID_179886 | |
| 0.004 | 0.314 | 0.526 | Cholecystokinin agonist | 0.526 0.002 CID_179886 | CID_179886 | |
| 0.071 | 0.411 | 0.924 | Angiogenesis inhibitor | 0.924 0.004 CID_179886 | CID_179886 | |
| 0.013 | 0.46 | 0.115 | Thrombin inhibitor | 0.115 0.019 CID_179886 | CID_179886 | |
| 0.02 | 0.509 | 0.156 | Multidrug resistance-associated protein 1 inhibitor | 0.156 0.023 CID_179886 | CID_179886 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |